NO981071L - Hydrolyse-fremmende taksan-hydrofobiske derivater - Google Patents

Hydrolyse-fremmende taksan-hydrofobiske derivater

Info

Publication number
NO981071L
NO981071L NO981071A NO981071A NO981071L NO 981071 L NO981071 L NO 981071L NO 981071 A NO981071 A NO 981071A NO 981071 A NO981071 A NO 981071A NO 981071 L NO981071 L NO 981071L
Authority
NO
Norway
Prior art keywords
taxane
hydrolysis
promoting
hydrocarbon
hydrophobic derivatives
Prior art date
Application number
NO981071A
Other languages
English (en)
Other versions
NO981071D0 (no
NO319521B1 (no
Inventor
Eric Mayhew
Shaukat Ali
Andrew Stuart Janoff
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of NO981071D0 publication Critical patent/NO981071D0/no
Publication of NO981071L publication Critical patent/NO981071L/no
Publication of NO319521B1 publication Critical patent/NO319521B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
NO19981071A 1995-09-12 1998-03-11 Hydrolysefremmende taksan-hydrofobiske derivater, sammensetninger og anvendelse derav. NO319521B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US357595P 1995-09-12 1995-09-12
PCT/US1996/014631 WO1997010234A1 (en) 1995-09-12 1996-09-12 Hydrolysis-promoting taxane hydrophobic derivatives

Publications (3)

Publication Number Publication Date
NO981071D0 NO981071D0 (no) 1998-03-11
NO981071L true NO981071L (no) 1998-05-12
NO319521B1 NO319521B1 (no) 2005-08-22

Family

ID=21706522

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19981071A NO319521B1 (no) 1995-09-12 1998-03-11 Hydrolysefremmende taksan-hydrofobiske derivater, sammensetninger og anvendelse derav.

Country Status (22)

Country Link
US (1) US5703117A (no)
EP (1) EP0902783B1 (no)
JP (1) JP4192208B2 (no)
KR (1) KR100401220B1 (no)
CN (1) CN1100770C (no)
AT (2) ATE309235T1 (no)
CA (1) CA2231750C (no)
CZ (1) CZ288562B6 (no)
DE (2) DE69620802T2 (no)
DK (2) DK0902783T3 (no)
ES (2) ES2179208T3 (no)
HK (1) HK1016169A1 (no)
HU (1) HU226325B1 (no)
IL (1) IL123595A (no)
MX (1) MX9801871A (no)
NO (1) NO319521B1 (no)
NZ (1) NZ318300A (no)
PL (1) PL187738B1 (no)
PT (1) PT902783E (no)
SK (1) SK283199B6 (no)
TR (1) TR199800443T1 (no)
WO (1) WO1997010234A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107332A (en) * 1995-09-12 2000-08-22 The Liposome Company, Inc. Hydrolysis-promoting hydrophobic taxane derivatives
US6667053B1 (en) * 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US5912264A (en) * 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
PT1964557E (pt) 1997-11-10 2013-02-20 Sloan Kettering Inst Cancer Processo para a produção de formulações de trióxido de arsénio
BR9911031A (pt) * 1998-05-20 2002-01-29 Liposome Co Inc Novas formulações em partìculas
US7314637B1 (en) 1999-06-29 2008-01-01 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US6146659A (en) * 1998-07-01 2000-11-14 Neopharm, Inc. Method of administering liposomal encapsulated taxane
DE60004630T2 (de) * 1999-01-12 2004-06-17 Quanam Medical Corp., Santa Clara Arzneimittel und verfahren zur verabreichung von wasserunlöslichen paclitaxelderivaten
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
CA2410632A1 (en) 2000-06-22 2001-12-27 David S. Garvey Nitrosated and nitrosylated taxanes, compositions and methods of use
US6607689B1 (en) * 2000-08-29 2003-08-19 Micron Technology, Inc. Layer thickness control for stereolithography utilizing variable liquid elevation and laser focal length
EP1304103B1 (en) * 2001-10-22 2008-12-31 Viroblock SA New non-phospholipid lipid vesicles (npLV) and their use in cosmetic, therapeutic and prophylactic applications
EP1461056A4 (en) * 2001-11-26 2006-01-25 Supergen Inc PROCESS FOR THE PREPARATION AND USE OF POLYOXYETHYLATED CICRIC OIL IN PHARMACEUTICAL COMPOSITIONS
AU2003249882B2 (en) * 2002-06-26 2008-09-18 Medigene Ag Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
WO2004069224A2 (en) 2003-02-03 2004-08-19 Neopharm, Inc. Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs
JP5139814B2 (ja) * 2005-02-18 2013-02-06 アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー 医療装置に結合した改善された疎水性を有した薬剤
WO2006110862A2 (en) * 2005-04-12 2006-10-19 Wisconsin Alumni Research Foundation Micelle composition of polymer and passenger drug
JP2011517683A (ja) * 2008-04-10 2011-06-16 アブラクシス バイオサイエンス， エルエルシー 疎水性タキサン誘導体の組成物およびその使用
AU2009234127B2 (en) * 2008-04-10 2015-04-30 Abraxis Bioscience, Llc Compositions of hydrophobic taxane derivatives and uses thereof
WO2011038278A2 (en) 2009-09-25 2011-03-31 Wisconsin Alumni Research Foundation Micelle encapsulation of therapeutic agents
CN105503844A (zh) * 2015-12-11 2016-04-20 上海大学 C-13和c-7位结构改造的紫杉醇类化合物及其制备方法
CN111004195B (zh) * 2019-12-03 2022-01-28 沈阳药科大学 卡巴他赛弱碱性衍生物及其制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278324A (en) * 1990-08-28 1994-01-11 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
EP0626953A4 (en) * 1992-12-23 1995-05-03 Bristol Myers Squibb Co NEW SIDE CHAINS WEARING TAXANS AND THEIR INTERMEDIATE PRODUCTS.
IL108316A (en) * 1993-01-15 2006-10-31 Univ Florida State History of C-10 Texan and pharmaceuticals containing them
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives

Also Published As

Publication number Publication date
MX9801871A (es) 1998-05-31
ATE309235T1 (de) 2005-11-15
ES2252347T3 (es) 2006-05-16
AU706290B2 (en) 1999-06-10
WO1997010234A1 (en) 1997-03-20
ES2179208T3 (es) 2003-01-16
HK1016169A1 (en) 1999-10-29
DE69635428T2 (de) 2006-06-14
PT902783E (pt) 2002-09-30
DE69620802T2 (de) 2002-10-10
PL325477A1 (en) 1998-07-20
TR199800443T1 (xx) 1998-06-22
PL187738B1 (pl) 2004-09-30
DK0902783T3 (da) 2002-07-22
HU226325B1 (en) 2008-08-28
NO981071D0 (no) 1998-03-11
CZ288562B6 (cs) 2001-07-11
CZ71198A3 (cs) 1998-07-15
EP0902783A4 (no) 1999-03-24
NO319521B1 (no) 2005-08-22
CN1100770C (zh) 2003-02-05
SK33498A3 (en) 1998-08-05
CA2231750A1 (en) 1997-03-20
EP0902783B1 (en) 2002-04-17
DE69620802D1 (de) 2002-05-23
US5703117A (en) 1997-12-30
CA2231750C (en) 2006-07-11
IL123595A (en) 2000-10-31
HUP9901433A2 (hu) 2001-04-28
EP0902783A1 (en) 1999-03-24
JP4192208B2 (ja) 2008-12-10
SK283199B6 (sk) 2003-03-04
KR100401220B1 (ko) 2004-03-20
NZ318300A (en) 1999-08-30
HUP9901433A3 (en) 2001-05-28
KR19990044409A (ko) 1999-06-25
IL123595A0 (en) 1998-10-30
AU6975696A (en) 1997-04-01
ATE216377T1 (de) 2002-05-15
DK1229030T3 (da) 2006-02-13
JP2001519755A (ja) 2001-10-23
DE69635428D1 (de) 2005-12-15
CN1202166A (zh) 1998-12-16

Similar Documents

Publication Publication Date Title
DK1229030T3 (da) Hydrolysefremmende, hydrofobe taxanderivater
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
PT802911E (pt) Derivados de taxano hidrofobos
CA2301057A1 (en) A method of administering liposomal encapsulated taxane
DE69226197D1 (de) Hämoglobine als arzneimittelabgabesystem
TR200102603T2 (tr) Antitümör aktiviteye sahip olan kamptotesin türevleri
PT977564E (pt) Forscolina para promocao da massa corporal magra
NL970006I2 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
ATE238733T1 (de) Inhalierbares kontrastmittel
DE59611341D1 (de) Verwendung von saccharid-konjugaten
CY1109695T1 (el) Μικροοργανισμοι αποδομησης οξαλικου ή ενζυμα αποδομησης οξαλικου για την προληψη παθησης σχετιζομενης με οξαλικο
ATE262515T1 (de) Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie
SE8404283D0 (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
EP1229030A3 (en) Hydrolysis-promoting taxane hydrophobic derivates
TR199901395T2 (xx) Yeni karboksi ikameli siklik karboksamid t�revleri.
PT1058544E (pt) Inibicao da actividade do tnf
ES8605989A1 (es) Un metodo de preparar un complejo de fibronectina, dextrano y farmaco
RU94018405A (ru) Устройство для воздействия магнитным полем
IT208536Z2 (it) Struttura di cannula vaginale monouso, per l'applicazione di pomate, medicamenti semidensi e simili.